ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Latigo Biotherapeutics Inc
22.37
+0.9700
4.53%
成交量:
19.72萬
成交額:
435.31萬
市值:
14.15億
市盈率:
-1.13
高:
22.90
開:
21.52
低:
20.64
收:
21.40
52周最高:
22.90
52周最低:
17.22
股本:
6,323.80萬
流通股本:
3,023.14萬
量比:
1.00
換手率:
0.65%
股息:
- -
股息率:
- -
每股收益(TTM):
-19.7441
每股收益(LYR):
-20.1159
淨資產收益率:
--
總資產收益率:
--
市淨率:
-5.60
市盈率(LYR):
-1.11
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
美股異動 | Latigo Biotherapeutics(LTGO.US)登陸美股市場 開盤後股價升逾14%
智通财经
·
08/08
異動解讀 | Latigo Biotherapeutics首日上市盤中大漲16.67%,生物科技IPO熱潮與創新管線獲市場追捧
异动解读
·
08/07
Latigo在將IPO規模擴大至3.456億美元后,即將於納斯達克首日上市,開盤有望走高
路透中文
·
08/07
非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元,Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場
智通财经
·
08/04
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/LTGO"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTGO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","market":"US","secType":"STK","nameCN":"Latigo Biotherapeutics Inc","latestPrice":22.37,"timestamp":1787342400000,"preClose":21.4,"halted":0,"volume":197197,"delay":0,"changeRate":0.04532710280373843,"floatShares":30231431,"shares":63238000,"eps":-19.74407,"marketStatus":"盤前交易","change":0.97,"latestTime":"08-24 08:58:01 EDT","open":21.52,"high":22.9,"low":20.6431,"amount":4353105.041285,"amplitude":0.105463,"askPrice":23,"askSize":1,"bidPrice":22.33,"bidSize":231,"shortable":3,"etf":0,"ttmEps":-19.74407,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":22.37,"postHourTrading":{"tag":"盘后","latestPrice":22.7,"preClose":22.37,"latestTime":"19:30 EDT","volume":1274,"amount":28918.44,"timestamp":1787355008159,"change":0.33,"changeRate":0.014752,"amplitude":0.014752},"volumeRatio":0.9968799012885303},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","floatShares":30231431,"roa":"--","roe":"--","lyrEps":-20.11587,"volumeRatio":0.9968799012885303,"shares":63238000,"dividePrice":0,"high":22.9,"amplitude":0.105463,"preClose":21.4,"low":20.6431,"week52Low":17.2201,"pbRate":"-5.60","week52High":22.9,"institutionHeld":0,"latestPrice":22.37,"committee":0.991379,"eps":-19.74407,"divideRate":0,"volume":197197,"delay":0,"ttmEps":-19.74407,"open":21.52,"prevYearClose":18,"prevWeekClose":22.37,"prevMonthClose":18,"prevQuarterClose":18,"fiveDayClose":19.49,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTGO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTGO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTGO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTGO","date":"2026-08-21","current":-1.132998,"percent":0,"low":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"high":-10.257227,"avg":-11.062207,"sd":0.589939,"marketCap":1353293842},"quantilePoints":[{"date":"2026-08-07","current":-10.257227,"twenty":-10.257227,"median":-10.257227,"eighty":-10.257227,"marketCap":1140357438},{"date":"2026-08-14","current":-11.41033,"twenty":-11.020695,"median":-10.545739,"eighty":-10.380784,"marketCap":1268554881},{"date":"2026-08-21","current":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"marketCap":1353293842}],"updateTime":1787569135987},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTGO\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657406616","title":"美股異動 | Latigo Biotherapeutics(LTGO.US)登陸美股市場 開盤後股價升逾14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657406616","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657406616?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 00:17","pubTimestamp":1786119476,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周五,非阿片止痛药开发商Latigo Biotherapeutics(LTGO.US)登陆美股市场,截至发稿,该股涨超14%,报20.53美元。Latigo致力于开发针对Nav1.8钠离子通道的非阿片类止痛药物。其核心候选药物LTG-001是一款口服Nav1.8抑制剂,主要用于治疗中度至重度急性疼痛,包括术后疼痛。这种药物旨在提供媲美阿片类药物的镇痛效果,同时避免成瘾风险。Nav1.8主要表达于外周疼痛感觉神经元,其抑制剂不作用于中枢神经系统,因此不具备成瘾性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LTGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126044680","title":"異動解讀 | Latigo Biotherapeutics首日上市盤中大漲16.67%,生物科技IPO熱潮與創新管線獲市場追捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1126044680","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126044680?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 23:42","pubTimestamp":1786117348,"startTime":"0","endTime":"0","summary":"生物科技公司Latigo Biotherapeutics今日盘中大涨16.67%,成为市场焦点。该股今日在纳斯达克首日上市,开盘后股价迅速走高,表现强劲。此次股价大涨主要得益于Latigo规模扩大的首次公开募股获得市场热烈响应。此外,公司上市正值生物科技板块IPO的黄金窗口期,2026年以来美国生物科技和制药企业IPO加权平均回报率高达55%,市场对具备差异化临床数据和明确市场机会的平台型公司兴趣浓厚,为Latigo的股价表现提供了有力支撑。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LTGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657764162","title":"Latigo在將IPO規模擴大至3.456億美元后,即將於納斯達克首日上市,開盤有望走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2657764162","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657764162?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:56","pubTimestamp":1786111014,"startTime":"0","endTime":"0","summary":"BUZZ-Latigo在将IPO规模扩大至3.456亿美元后,即将于纳斯达克首日上市,开盘有望走高8月7日-** 药物开发商Latigo Biotherapeutics(LTGO.O)完成3.456亿美元美国IPO后,纳斯达克首日上市开盘价有望高于发行价** 该股最新显示开盘价为每股20美元,高于18美元的发行价** 总部位于加利福尼亚州千橡市的LTGO公司通过规模扩大的首次公开募股,以每股18美","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4T44415Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNSH","IE0002270589.USD","LU1804176565.USD","LU2237443465.HKD","IE0004086264.USD","BK4533","LU2237443895.HKD","IE00B19Z3581.USD","LU0048573561.USD","LU0061475181.USD","BK4516","LU0096364046.USD","LU2471134523.USD","LU1894683264.USD","IE0034235188.USD","LU2471134952.CNY","LU0345770993.USD","IE00BFXG1179.USD","BK4207","LU0345770308.USD","LU0942090050.USD","LU2237443978.SGD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU2237443382.USD","BK4585","LU2237443622.USD","LU1668664300.SGD","BK4550","LU0251131958.USD","LU0742534661.SGD","LU0868494708.USD","LU1868836591.USD","BK4552","LU2750360997.AUD","LU1791807156.HKD","BK4588","LU0106831901.USD","GSX","LU1894683348.USD","LU1868837300.USD","LU1868837136.USD","LU2265009873.SGD","LU1868836757.USD","LU2237443549.SGD","LTGO","LU1868836914.USD","IE0004091025.USD","LU2750360641.GBP","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539622","title":"非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元,Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656539622?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:59","pubTimestamp":1785833974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0058720904.USD","VRTX","BK4585","LU1585245621.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","BBH","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","BIB","LU1093756168.USD","IE0002141913.USD","IDNA","KCE","REDS","LU2468319806.SGD","LU0234570918.USD","BK4532","TBXU","LU0823416689.USD","BK4139","LU0417517546.SGD","IE00BJJMRZ35.SGD","IBBQ","LU0289739699.SGD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","LU2324357040.USD","PBE","LU2362541273.HKD","SG9999013999.USD","FRHC","GNMX","LU0256863811.USD","IPOS","IBB","IE00BZ9MQY76.HKD","LU2456880835.USD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU2362541513.USD","LU1093756325.SGD","BK4127","LU1778281490.HKD","LTGO","BK4588","BK4533","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LTGO\",params:#limit:6,delay:false,,,undefined,":[]}}